In addition, fasting blood glucose, fasting insulin levels, and the insulin resistance index (HOMA-IR) were also improved in metformin-treated T2DM mice, as shown in Supplementary Figure S1C–E. The gene discussed is INS; the disease is type 2 diabetes mellitus.